Industry Reports

Q3-2017 Anesthesia Services Update– The anesthesia services sector remained active during the third quarter of 2017. Two new private equity platforms emerged within the interventional pain management segment, and strategic consolidators in the ambulatory and hospital based segment continued to expand through add-on acquisitions.

Q3-2017 Behavioral Health Update– The behavioral health sector has been one of the most active areas within healthcare for the better part of the last two years and the third quarter of 2017 was no different. With 11 transactions taking place over the last quarter, six of which included either a private equity group or a private equity-backed acquirer, the sector continues to see heavy deal volume.

Q3-2017 CRO Update– The current state of the contract research organization industry continues to be largely shaped by the super mergers of the past. The landscape for mid-sized CRO’s has drastically changed as the revenue gap has widened between mega-CRO’s and the rest of the industry.

Q3-2017 Dental Services Update– Merger & acquisition activity within the dental sector remained elevated during the third quarter of 2017. Consolidators remained active in acquiring add-on acquisitions to their platforms, while several new private equity platforms emerged.

Q3-2017 Dermatology Update– Dermatology remains one of the most active sectors within physician services as private equity capital continues to flow into the sector. Private equity-backed groups continued to aggressively executive add-on strategies throughout the country in the third quarter of 2017.

Q3-2017 Emergency Medical Services Update– The emergency medical services sector witnessed several landmark transactions in the third quarter of the year, which was supported by significant private equity interest and investment within the industry.

Q3-2017 Healthcare IT Update– Strong deal flow in the healthcare IT sector persisted in the third quarter as strategic acquirers and private equity groups sought out providers of data analytics and EHR systems.

Q3-2017 Home Health & Hospice Industry Update– Amongst the sub-divisions of home healthcare, there was particularly strong transaction activity within non-skilled personal care during the third quarter. Both Medicaid-reimbursed personal care and private pay have attracted considerable attention recently, with the franchisor model seemingly being preferable for the latter.

Q3-2017 Laboratory Services Update– The laboratory services market continues to be dominated by two global providers; LabCorp and Quest Diagnostics. With the Centers for Medicare and Medicaid releasing a draft of 2018 reimbursement rates in September, the industry could see as much as a 10% hits to reimbursement rates across the board. While a decrease was anticipated, this outcome is far worse than anyone expected. The ability to leverage size and scale has allowed the industry’s largest providers to capitalize on this news.

Q3-2017 Ophthalmology Update– Consolidation within Vision Care showed no signs of slowing in the third quarter. With more platform investments in the sector, Provident expects add-on acquisition activity to pick up considerably in the coming quarters.

Q3-2017 Pharmacy Services Update– Strategic buyers continued to consolidate the pharmacy services market, sustaining the rate they set in the first two quarters of 2017. Private equity investors were also active this quarter as they look to build pharmacy services platforms.

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”